In last trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 0.46 million shares changing hands with its beta currently measuring -0.41. Company’s recent per share price
In last trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 17.48 million shares changing hands with its beta currently measuring -0.40. Company’s recent per share price
NLS Pharmaceutics Ltd (NASDAQ:NLSP) has a beta value of -0.40 and has seen 15.01 million shares traded in the last trading session. The company, currently
In the last trading session, 21.29 million shares of the NLS Pharmaceutics Ltd (NASDAQ:NLSP) were traded, and its beta was -0.43. Most recently the company’s
In today’s recent session, 19.24 million shares of the NLS Pharmaceutics Ltd (NASDAQ:NLSP) have been traded, and its beta is -0.43. Most recently the company’s
In last trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 1.49 million shares changing hands with its beta currently measuring -0.38. Company’s recent per share price
In the last trading session, 1.13 million shares of the NLS Pharmaceutics Ltd (NASDAQ:NLSP) were traded, and its beta was -0.49. Most recently the company’s
In today’s recent session, 1.1 million shares of the NLS Pharmaceutics Ltd (NASDAQ:NLSP) have been traded, and its beta is -0.49. Most recently the company’s
In the last trading session, 3.65 million NLS Pharmaceutics Ltd (NASDAQ:NLSP) shares changed hands as the company’s beta touched -0.52. With the company’s per share
In the latest trading session, 3.43 million NLS Pharmaceutics Ltd (NASDAQ:NLSP) shares changed hands as the company’s beta touched -0.52. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
